News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Casdin Capital, LLC
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/11/2023 |
4
| Casdin Partners Master Fund, L.P. (10% Owner) has filed a Form 4 on BIOLIFE SOLUTIONS INC|
Txns:
| Bought 58,465 shares
@ $13.2001, valued at
$771.7k
|
|
| 05/23/2023 |
4
| Casdin Partners Master Fund, L.P. (10% Owner) has filed a Form 4 on BIOLIFE SOLUTIONS INC|
Txns:
| Bought 50,000 shares
@ $22.5486, valued at
$1.1M
Bought 24,973 shares
@ $21.8552, valued at
$545.8k
|
|
| 05/19/2023 |
4
| Casdin Partners Master Fund, L.P. (10% Owner) has filed a Form 4 on STANDARD BIOTOOLS INC.|
Txns:
| Bought 250,000 shares
@ $1.8862, valued at
$471.6k
Bought 150,000 shares
@ $2.1591, valued at
$323.9k
Bought 800,000 shares
@ $2.2949, valued at
$1.8M
|
|
| 05/18/2023 |
4
| Casdin Partners Master Fund, L.P. (10% Owner) has filed a Form 4 on BIOLIFE SOLUTIONS INC|
Txns:
| Bought 15,000 shares
@ $20.189, valued at
$302.8k
Bought 30,027 shares
@ $21.2957, valued at
$639.4k
Bought 30,000 shares
@ $21.7564, valued at
$652.7k
|
|
| 11/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/05/2022 |
4
| Casdin Partners Master Fund, L.P. (10% Owner) has filed a Form 4 on MAXCYTE, INC.|
Txns:
| Sold 735,786 shares
@ $6.15, valued at
$4.5M
|
|
| 07/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/06/2022 |
4
| Casdin Partners Master Fund, L.P. (10% Owner) has filed a Form 4 on STANDARD BIOTOOLS INC.|
Txns:
| Granted 127,780 convertible preferred
@ $0 |
|
| 11/03/2021 |
4
| Casdin Partners Master Fund, L.P. (10% Owner) has filed a Form 4 on BIOLIFE SOLUTIONS INC|
Txns:
| Acquired 126,185 shares
@ $0 |
|
| 08/04/2021 |
4
| Casdin Partners Master Fund, L.P. (10% Owner) has filed a Form 4 on Tenaya Therapeutics, Inc.|
Txns:
| Converted 2,374,849 shares
@ $0
Bought 850,000 shares
@ $15, valued at
$12.8M
Converted 361,969 shares
@ $0
Converted 2,012,880 preferred shares
@ $0
Converted 361,969 preferred shares
@ $0
Converted 361,969 preferred shares
@ $0 |
|
| 08/03/2021 |
4
| Casdin Partners Master Fund, L.P. (10% Owner) has filed a Form 4 on MAXCYTE, INC.|
Txns:
| Bought 1,800,000 shares
@ $13, valued at
$23.4M
|
|
| 07/28/2021 |
4
| Casdin Partners Master Fund, L.P. (Director) has filed a Form 4 on Absci Corp|
Txns:
| Converted 4,209,573 shares
@ $0
Converted 973,260 shares
@ $0
Bought 1,562,500 shares
@ $16, valued at
$25M
Converted 973,260 shares
@ $0
Converted 1,274,431 preferred shares
@ $0
Converted convertible notes
@ $13.12, valued at
$0
Converted convertible notes
@ $13.12, valued at
$0 |
|
| 11/27/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/26/2020 |
4
| Casdin Partners Master Fund, L.P. (10% Owner) has filed a Form 4 on BIOLIFE SOLUTIONS INC|
Txns:
| Bought 476,191 shares
@ $10.5, valued at
$5M
|
|
| 05/18/2020 |
4
| Casdin Partners Master Fund, L.P. (10% Owner) has filed a Form 4 on BIOLIFE SOLUTIONS INC|
Txns:
| Bought 1,904,762 shares
@ $10.5, valued at
$20M
|
|
| 11/21/2019 |
4
| Casdin Partners Master Fund, L.P. (10% Owner) has filed a Form 4 on BIOLIFE SOLUTIONS INC|
Txns:
| Bought 20,000 shares
@ $15.1459, valued at
$302.9k
Bought 20,000 shares
@ $15.6809, valued at
$313.6k
|
|
| 07/22/2019 |
4
| Casdin Capital, LLC (10% Owner) has filed a Form 4 on Fulcrum Therapeutics, Inc.|
Txns:
| Converted 464,285 shares
@ $0
Bought 125,000 shares
@ $16, valued at
$2M
Bought 10,000 shares
@ $14.4996, valued at
$145k
Bought 5,000 shares
@ $14.4998, valued at
$72.5k
Converted 3,250,000 preferred shares
@ $0 |
|
| 07/23/2018 |
4
| Casdin Capital, LLC (10% Owner) has filed a Form 4 on CONSTELLATION PHARMACEUTICALS INC|
Txns:
| Converted 345,783 shares
@ $0
Bought 266,667 shares
@ $15, valued at
$4M
Converted 158,960 shares
@ $0
Converted 1,333,333 preferred shares
@ $0
Converted 342,435 preferred shares
@ $0
Converted 1,750,000 preferred shares
@ $0 |
|
|
|